Nippon India Pharma Fund - IDCW Option

0
Sectoral-Pharma and Healthcare NAV 74.6310 -1.48 23 May, 2022
Nippon India Pharma Fund - IDCW Option was previously known as

Reliance Pharma Fund - Dividend - Payout

Fund Details

Category Sectoral-Pharma and Healthcare
Fund Type Open Ended
Investment Plan Dividend
Launch Date 05 June, 2004
Benchmark S&P BSE Healthcare
Asset Size(Cr) 4931.89 (As on 31-03-2022)
Turn over 38.00%
Min Investment ₹ 5000
Min SIP Investment ₹ 100
Min Addl Investment ₹ 1000
Exit Load 1% for redemption within 30 days
Expense Ratio 1.8% (As on 31-03-2022)
Fund Manager Sailesh Raj Bhan

Investment Returns (As on 23 May, 2022)

Duration Returns Benchmark Category
1 W 0.54% -1.99% -2.26%
1 M -7.35% -0.24% -0.87%
3 M -3.49% 2.97% 0.68%
6 M -10.39% -4.26% -4.94%
1 Y -7.53% 4% 4.48%
2 Y 24.68% 17.6% 23.84%
3 Y 23.44% 14.81% 23.34%
5 Y 16.9% 8.11% 13.23%

Risk Mesasures (As on 23 May, 2022)

Std Dev Sharpe Beta Alpha
Fund 15.77 0.32 1.92 0.97
Benchmark 0 0 0 0
Returns Compare with Others
  • 1Y
  • 3Y
  • 5Y

Portfolio (As on 28 Feb, 2022)

Assets Allocation

Sector Holdings
Others 1.68%

Return Calculator

  • ₹0 (0.0)
  • ₹0 (0.0)
  • ₹0 (0.0)

Disclaimer: Above returns are calculated on the basis of historical NAV movement for the selected period. However, historical performance does not guarantee future returns. Investors must take investment decisions based on his/her own requirements.

Peer Comparison

Fund Name 1 Yr Rtn. 3 Yr Rtn. 5 Yr Rtn.
Nippon India Pharma Fund - IDCW Option -7.53% 23.44% 16.9%
Nippon India Pharma Fund-Growth Plan-Growth Option -7.53% 23.44% 16.9%
SBI Healthcare Opportunities Fund - Regular Plan -Growth -7.9% 22.57% 11%
Tata India Pharma & Healthcare Fund-Regular Plan-Growth -3.34% 22.38% 12.86%

Fill this form now to make an investment!

Add to Cart Successfully
Add to Cart Successfully